Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...

Researchers employed a technique that can allow the discovery of novel microbiome-produced metabolites not seen under standard laboratory conditions.

Stool-based tests that combine microbial markers such as Fusobacterium nucleatum, colibactin-positive E. coli and ...

A new experimental antibiotic has stunned researchers by wiping out dangerous bacteria at concentrations roughly two orders ...

Wockhardt Ltd shares jumped over 4% to ₹1,533, extending a two-day rally after surging nearly 20% on Tuesday. The rise follows the US FDA’s acceptance of its New Drug Application for Zaynich, a ...

The global rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria has emerged as a ...

An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...

Colibactin is a powerful toxin produced by Escherichia coli and other bacteria living in the human gut. This highly unstable ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

The market capitalization of the company has soared by Rs 5,400 crore in these two days of sharp gains to Rs 25,493 crore.

People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while ...

The microbes inside our bodies not only help break down food but also impact our health. Yet their precise influence is not ...